| 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult TJ Anderson, J Grégoire, RA Hegele, P Couture, GBJ Mancini, ... Canadian Journal of Cardiology 29 (2), 151-167, 2013 | 1128 | 2013 |
| 2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult TJ Anderson, J Grégoire, GJ Pearson, AR Barry, P Couture, M Dawes, ... Canadian Journal of Cardiology 32 (11), 1263-1282, 2016 | 1100 | 2016 |
| 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult–2009 recommendations J Genest, R McPherson, J Frohlich, T Anderson, N Campbell, ... Canadian Journal of Cardiology 25 (10), 567-579, 2009 | 1067 | 2009 |
| 2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults GJ Pearson, G Thanassoulis, TJ Anderson, AR Barry, P Couture, N Dayan, ... Canadian journal of cardiology 37 (8), 1129-1150, 2021 | 713 | 2021 |
| Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Consensus Working Group Update (2016) GBJ Mancini, S Baker, J Bergeron, D Fitchett, J Frohlich, J Genest, ... Canadian Journal of Cardiology 32 (7), S35-S65, 2016 | 325 | 2016 |
| Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update GBJ Mancini, AY Tashakkor, S Baker, J Bergeron, D Fitchett, J Frohlich, ... Canadian Journal of Cardiology 29 (12), 1553-1568, 2013 | 237 | 2013 |
| Evolution in the practice of pharmacy—not a revolution! GJ Pearson Cmaj 176 (9), 1295-1296, 2007 | 170 | 2007 |
| Canadian Cardiovascular Society position statement on familial hypercholesterolemia: update 2018 LR Brunham, I Ruel, S Aljenedil, JB Rivière, A Baass, JV Tu, GBJ Mancini, ... Canadian Journal of Cardiology 34 (12), 1553-1563, 2018 | 144 | 2018 |
| Familial hypercholesterolemia: Review of diagnosis, screening, and treatment RD Turgeon, AR Barry, GJ Pearson Canadian family physician 62 (1), 32-37, 2016 | 114 | 2016 |
| A systematic review of the evidence for pharmacist care of patients with dyslipidemia TL Charrois, M Zolezzi, SL Koshman, G Pearson, M Makowsky, T Durec, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32 (3 …, 2012 | 105 | 2012 |
| Correlation of cardiovascular magnetic resonance imaging findings and endomyocardial biopsy results in patients undergoing screening for heart transplant rejection CR Butler, AM Savu, JA Bakal, M Toma, R Thompson, K Chow, H Wang, ... The Journal of Heart and Lung Transplantation 34 (5), 643-650, 2015 | 93 | 2015 |
| Use of OTC and herbal products in patients with cardiovascular disease C Pharand, ML Ackman, CA Jackevicius, FL Paradiso-Hardy, GJ Pearson Annals of Pharmacotherapy 37 (6), 899-904, 2003 | 83 | 2003 |
| A randomized trial of a community-based approach to dyslipidemia management: Pharmacist prescribing to achieve cholesterol targets (RxACT Study) RT Tsuyuki, M Rosenthal, GJ Pearson Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 149 (5), 283-292, 2016 | 81 | 2016 |
| Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update SW Tobe, JA Stone, T Anderson, S Bacon, AYY Cheng, ... Cmaj 190 (40), E1192-E1206, 2018 | 69 | 2018 |
| Long‐term impact of a community pharmacist intervention on cholesterol levels in patients at high risk for cardiovascular events: Extended follow‐up of the second study of … C Yamada, JA Johnson, P Robertson, G Pearson, RT Tsuyuki Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 25 (1 …, 2005 | 54 | 2005 |
| Tolerability of statin-fibrate and statin-niacin combination therapy in dyslipidemic patients at high risk for cardiovascular events TH Taher, V Dzavik, EM Reteff, GJ Pearson, BL Woloschuk, GA Francis The American journal of cardiology 89 (4), 390-394, 2002 | 54 | 2002 |
| Professional Use of Social Media by Pharmacists AR Barry, GJ Pearson The Canadian journal of hospital pharmacy 68 (1), 22-7, 2015 | 53 | 2015 |
| Cardiovascular efficacy and safety of PCSK9 inhibitors: systematic review and meta-analysis including the ODYSSEY OUTCOMES trial RD Turgeon, RT Tsuyuki, GT Gyenes, GJ Pearson Canadian Journal of Cardiology 34 (12), 1600-1605, 2018 | 48 | 2018 |
| Supratherapeutic response to ezetimibe administered with cyclosporine SL Koshman, LD Lalonde, I Burton, WJ Tymchak, GJ Pearson Annals of Pharmacotherapy 39 (9), 1561-1565, 2005 | 45 | 2005 |
| Are the ACC/AHA guidelines on the treatment of blood cholesterol a game changer? A perspective from the Canadian Cardiovascular Society Dyslipidemia Panel TJ Anderson, J Grégoire, RA Hegele, P Couture, GBJ Mancini, ... Canadian Journal of Cardiology 30 (4), 377-380, 2014 | 39 | 2014 |
Rob HegeleWestern University, Robarts Research InstituteVerified email at robarts.ca